These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 27705964)

  • 1. Interaction with the MAPT H1H1 Genotype Increases Dementia Risk in APOE ε4 Carriers in a Population of Southern India.
    Jairani PS; Aswathy PM; Gopala S; Verghese J; Mathuranath PS
    Dement Geriatr Cogn Disord; 2016; 42(5-6):255-264. PubMed ID: 27705964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of MAPT H1 and APOE ε4 on transition from mild cognitive impairment to dementia.
    Samaranch L; Cervantes S; Barabash A; Alonso A; Cabranes JA; Lamet I; Ancín I; Lorenzo E; Martínez-Lage P; Marcos A; Clarimón J; Alcolea D; Lleó A; Blesa R; Gómez-Isla T; Pastor P
    J Alzheimers Dis; 2010; 22(4):1065-71. PubMed ID: 20930301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of
    Qian J; Betensky RA; Hyman BT; Serrano-Pozo A
    Neurology; 2021 May; 96(19):e2414-e2428. PubMed ID: 33771840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of apolipoprotein E epsilon 3 on sporadic Alzheimer's disease in the Chinese population: a meta-analysis.
    Chen Q; Wang T; Kang D; Chen L
    Sci Rep; 2022 Aug; 12(1):13620. PubMed ID: 35948759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects.
    Engelborghs S; Dermaut B; Goeman J; Saerens J; Mariën P; Pickut BA; Van den Broeck M; Serneels S; Cruts M; Van Broeckhoven C; De Deyn PP
    J Neurol Neurosurg Psychiatry; 2003 Aug; 74(8):1148-51. PubMed ID: 12876259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
    J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between APOE polymorphisms and seven diseases with cognitive impairment including Alzheimer's disease, frontotemporal dementia, and dementia with Lewy bodies in southeast China.
    Chen KL; Sun YM; Zhou Y; Zhao QH; Ding D; Guo QH
    Psychiatr Genet; 2016 Jun; 26(3):124-31. PubMed ID: 26981880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementia.
    Salvadó G; Grothe MJ; Groot C; Moscoso A; Schöll M; Gispert JD; Ossenkoppele R;
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(7):2212-2224. PubMed ID: 33521872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E genotypes in hospitalized elderly patients with vascular dementia.
    Orsitto G; Seripa D; Panza F; Franceschi M; Cascavilla L; Placentino G; Matera MG; Paris F; Capurso C; Solfrizzi V; Dallapiccola B; Pilotto A
    Dement Geriatr Cogn Disord; 2007; 23(5):327-33. PubMed ID: 17374951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E gene in physiological and pathological aging.
    Ferri E; Gussago C; Casati M; Mari D; Rossi PD; Ciccone S; Cesari M; Arosio B
    Mech Ageing Dev; 2019 Mar; 178():41-45. PubMed ID: 30658061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Variation in the Ontario Neurodegenerative Disease Research Initiative.
    Dilliott AA; Evans EC; Farhan SMK; Ghani M; Sato C; Zhang M; McIntyre AD; Cao H; Racacho L; Robinson JF; Strong MJ; Masellis M; Bulman DE; Rogaeva E; Black SE; Finger E; Frank A; Freedman M; Hassan A; Lang A; Shoesmith CL; Swartz RH; Tang-Wai D; Tartaglia MC; Turnbull J; Zinman L; ; Hegele RA
    Can J Neurol Sci; 2019 Sep; 46(5):491-498. PubMed ID: 31217043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updated meta-analysis of the role of APOE ε2/ε3/ε4 alleles in frontotemporal lobar degeneration.
    Su WH; Shi ZH; Liu SL; Wang XD; Liu S; Ji Y
    Oncotarget; 2017 Jul; 8(27):43721-43732. PubMed ID: 28487499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissecting the gene dose-effects of the APOE ε4 and ε2 alleles on hippocampal volumes in aging and Alzheimer's disease.
    Hostage CA; Roy Choudhury K; Doraiswamy PM; Petrella JR;
    PLoS One; 2013; 8(2):e54483. PubMed ID: 23405083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of apolipoprotein E genetic variation in Alzheimer's disease in Indian population: a meta-analysis.
    Agarwal R; Tripathi CB
    Am J Alzheimers Dis Other Demen; 2014 Nov; 29(7):575-82. PubMed ID: 25551132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of MAPT haplotype-tagging polymorphisms with cerebrospinal fluid biomarkers of Alzheimer's disease: A preliminary study in a Croatian cohort.
    Babić Leko M; Willumsen N; Nikolac Perković M; Klepac N; Borovečki F; Hof PR; Sonicki Z; Pivac N; de Silva R; Šimić G
    Brain Behav; 2018 Nov; 8(11):e01128. PubMed ID: 30329219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additive effect of LRP8/APOER2 R952Q variant to APOE epsilon2/epsilon3/epsilon4 genotype in modulating apolipoprotein E concentration and the risk of myocardial infarction: a case-control study.
    Martinelli N; Olivieri O; Shen GQ; Trabetti E; Pizzolo F; Busti F; Friso S; Bassi A; Li L; Hu Y; Pignatti PF; Corrocher R; Wang QK; Girelli D
    BMC Med Genet; 2009 May; 10():41. PubMed ID: 19439088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Apolipoprotein E ε2 vs ε4, Age, and β-Amyloid in Adults Without Cognitive Impairment.
    Insel PS; Hansson O; Mattsson-Carlgren N
    JAMA Neurol; 2021 Feb; 78(2):229-235. PubMed ID: 33044487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total Cholesterol and APOE-Related Risk for Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative.
    Dunk MM; Driscoll I;
    J Alzheimers Dis; 2022; 85(4):1519-1528. PubMed ID: 34958023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E ε4 allele is associated with vascular cognitive impairment no dementia in Chinese population.
    Han Y; Zhou A; Li F; Wang Q; Xu L; Jia J
    J Neurol Sci; 2020 Feb; 409():116606. PubMed ID: 31865187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.